Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D03301 (
PDL
)
658
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Regulation of the expression of
cAMP-dependent protein kinase
in cellular aging was studied using the IMR-90 diploid human lung fibroblasts. The level of
cAMP-dependent protein kinase
present in cell extracts was monitored by 1) photoactivated incorporation of 8-N3-[32P]cAMP into the 47,000- and 54,000-dalton regulatory subunits of the type I and type II cAMP-dependent protein kinases, respectively; 2) cAMP-dependent phosphorylation of histone II AS catalyzed by the catalytic subunit of the kinase; and 3) fractionation and analysis of the type I and type II
cAMP-dependent protein kinase
by DEAE-Sephacel column chromatography. Our results showed an approximately two- to threefold increase in the level of the type I
cAMP-dependent protein kinase
and a somewhat smaller increase in the type II kinase in extracts of the "old" IMR-90 cells (population doubling greater than 48) as compared to that of the "young" cells (
PDL
22-27). The timing of the increase in
cAMP-dependent protein kinase
coincided with a significant decrease in the proliferative potential of the cells. This result together with previously demonstrated effects of cAMP in the control of cell growth and differentiation and the increased expression of
cAMP-dependent protein kinase
during terminal differentiation of the murine preadipocytes (3T3-L1) and myoblast (L-5, L-6, and C2C13) suggests that regulation of the levels of cAMP and
cAMP-dependent protein kinase
plays a significant role in the control of cell growth and differentiation.
...
PMID:Increased level of cAMP-dependent protein kinase in aging human lung fibroblasts. 301 85